IT - EN
Last News   ERYTECH ANNOUNCES WITHDRAWAL OF ITS EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR GRASPA FOR ACUTE LYMPHOBASTIC LEUKEMIA AND PREPARES FOR RESUBMISSION  Notizie finanziarie e nuove iniziative